Yungjin Pharm. Co., Ltd. (KRX: 003520)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,907.00
-73.00 (-3.69%)
Dec 20, 2024, 3:30 PM KST

Yungjin Pharm. Company Description

Yungjin Pharm. Co., Ltd. operates as a pharmaceutical company in South Korea and internationally. It offers cephalosporin antibiotic, antipsychotic, cardiovascular, gastrointestinal, metabolic, neuropsychiatry, respiratory, infectious, anti-inflammatory and analgesics, nutritional supplement, and urology products.

The company also provides vitamins, minerals, and other products; and APIs. Yungjin Pharm.

Co., Ltd. was founded in 1952 and is headquartered in Seoul, South Korea. Yungjin Pharm.

Co., Ltd. operates as a subsidiary of KT&G Corporation.

Yungjin Pharm. Co., Ltd.
Country South Korea
Founded 1952
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 574
CEO Chae-Joon Lee

Contact Details

Address:
Jamsil Company Building
Seoul, 05510
South Korea
Phone 82 2 2041 8200
Website yungjin.co.kr

Stock Details

Ticker Symbol 003520
Exchange Korea Stock Exchange
Fiscal Year January - December
Reporting Currency KRW
ISIN Number KR7003520004
SIC Code 2834

Key Executives

Name Position
Chae-Joon Lee Chief Executive Officer and President